|Bid||0.00 x 100|
|Ask||0.00 x 100|
|Day's Range||76.89 - 78.32|
|52 Week Range||65.20 - 110.12|
|Beta (3Y Monthly)||0.19|
|PE Ratio (TTM)||70.28|
|Earnings Date||Jan 28, 2019 - Feb 1, 2019|
|Forward Dividend & Yield||2.20 (2.96%)|
|1y Target Est||92.33|
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Dividends play a key role in compounding returns over time and can form a large part of our portfolio return. Historically, The Scotts Miracle-Gro Company (NYSE:SMG) has been paying a Read More...
Scotts Miracle-Gro's (SMG) Hawthorne segment witnesses strong sales growth in Q4. It expects adjusted EPS in the band of $4.10-$4.30 for fiscal 2019.
The Scotts Miracle-Gro Company (SMG), the world’s leading marketer of branded consumer lawn and garden products, announced that its Board of Directors has approved the payment of a cash dividend of $0.55 per share. The Scotts Miracle-Gro Company is the world's largest marketer of branded consumer products for lawn and garden care. The Company's brands are among the most recognized in the industry.
The Democrats' return to the majority in the U.S. House of Representatives bodes well for Scotts Miracle-Gro Co.'s business supplying marijuana growers, CEO Jim Hagedorn said, as the Marysville company looks to bounce back from a rough 2018.
Scotts (SMG) delivered earnings and revenue surprises of -11.94% and -1.98%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The Marysville, Ohio-based company said it had a loss of $2.65 per share. Losses, adjusted for asset impairment costs and to account for discontinued operations, came to 75 cents per share. The results ...
Scotts Miracle-Gro Co.'s shares slid 3.7% in premarket trade Wednesday, after the lawn and garden care company missed profit and sales estimates for its fiscal fourth quarter. The company said it had a net loss of $146.9 million, or $2.36 a share, in the quarter to September 30, wider than the loss of $33.4 million, or 72 cents a share, in the year-earlier period. The adjusted per-share loss came to 75 cents, wider than the 67 cent FactSet consensus. Sales rose to $433.9 million from $376.7 million, missing the FactSet consensus of $441 million. Chief Executive Jim Hagedorn said fiscal 2018 was one of the company's most challenging years in recent memory. "Our U.S. Consumer business, however, had a strong second half following unfavorable early season weather. The Hawthorne team also made substantial progress in recent months, integrating the Sunlight acquisition to enable strong benefits for 2019." The company said it now expects sales to grow 10% to 11% in fiscal 2019. "We expect pricing will add 3 percent to the U.S. Consumer segment on a full-year basis, but also anticipate some unit decline from retailer merchandising decisions and continued inventory productivity initiatives," Chief Financial Officer Randy Coleman said. "Additionally, the contractual changes in our Roundup marketing agreement will result in an approximate 100 basis point decline to sales in this segment on a full-year basis." Shares have fallen 33.7% in 2018, while the S&P 500 has gained 3.1%.
Operating cash flow of $343 million aided by working capital improvement, lower taxesHawthorne acquisitions led to Company-wide sales growth of 15% in Q4; 1% for full year, Q4.
On Wednesday, Nov. 7, Scotts Miracle Gro (NYSE: SMG ) will release its latest earnings report. Benzinga's outlook for Scotts Miracle Gro is included in the following report. Earnings and Revenue Wall Street ...
The legalization of medical marijuana and recreational marijuana have emerged as key talking points in the run up to the election. Seven states have already legalized recreational marijuana, while roughly 30 other states have passed medical cannabis in some form. On Tuesday, four more states could be added to those lists. Legalization of the drug for recreational use is on the ballot in North Dakota and Michigan, while voters in Missouri and Utah will decide whether to legalize cannabis for medical purposes.
Naturally, this has significant implications for marijuana stocks. Favorable legislation stateside and in Canada boosted marijuana stocks like Tilray (NASDAQ:TLRY) into the stratosphere. While the pain is extremely pronounced for pot stocks, I believe the political environment presents high-risk/high-reward contrarian opportunities.
Pot stocks have crumbled, and Cronos Group (NASDAQ:CRON) has been one of the victims of the sell-off. CRON stock more than doubled from early August levels. The catalyst seems to be what Luke Lango presciently predicted would be a “sell the news” event: the official legalization of marijuana on Oct. 17.
NEW YORK, Oct. 29, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Which stock wins in a matchup between a high-flying clinical-stage biotech and a leading supplier to the marijuana industry?
The Scotts Miracle-Gro Company (NYSE SMG), the world’s largest marketer of branded consumer lawn and garden products, will release its fourth quarter financial results on Wednesday, November 7, 2018, prior to the opening of the U.S. financial markets. The Company will host a conference call to discuss those results at 9:00 a.m. ET. A live webcast of the call and the press release will be available on Company’s investor relations website at http://investor.scotts.com. An archive of the press release and any accompanying information will remain available for at least a 12-month period.
The Scotts Miracle-Gro Foundation and Ocean Research & Conservation Association (ORCA) today announced a new ‘Living Lagoon’ school program partnership that will expand access to hands-on programs for middle-school students living near the Indian River Lagoon. The ‘Living Lagoon’ program engages students with hands-on environmental education that helps address impairment issues along the lagoon while inspiring the next generation of stewards for Florida's waterways.
The Company recently filed its financial statements and corresponding MD&A and certifications for the fiscal years ended March 31, 2017 and 2018. It has also filed its interim financial statements, MD&A and certifications for the three months ended June 30, 2018. The Company’s current officers and directors are: Carl von Einsiedel – CEO and interim CFO and Director, and Garth Kirkham - Director. The Company intends to add additional directors so as to comply with TSX Venture Exchange policies. In that regard, the Company has scheduled an annual and special shareholders’ meeting for November 9, 2018. The Company recently filed notice that it changed its auditor from De Visser Gray LLP to Wolrige Mahon LLP. The Company noted that (i) De Visser had not expressed any reservation in its reports for, and (ii) no “reportable event” as defined in NI 51-102, had occurred with respect to the most recently completed fiscal year (2013) for which De Visser issued an audit report in respect of the Company, nor for the period therefrom to the date of the notice.
The market watcher's comments come just as recreational marijuana is legalized in Canada on Wednesday. Damodaran expects the industry's key players to remain in Canada, while business in the U.S. is "handicapped" by differing regulations between the state and federal levels.